Last reviewed · How we verify
Systane Ultra UD
Systane Ultra UD is an artificial tear solution that lubricates and protects the ocular surface to relieve dry eye symptoms.
Systane Ultra UD is an artificial tear solution that lubricates and protects the ocular surface to relieve dry eye symptoms. Used for Dry eye disease / Keratoconjunctivitis sicca.
At a glance
| Generic name | Systane Ultra UD |
|---|---|
| Sponsor | Ocuwize LTD |
| Drug class | Artificial tear / Ocular lubricant |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | FDA-approved |
Mechanism of action
The formulation contains a combination of lubricating agents (polyethylene glycol 400 and propylene glycol) along with an electrolyte solution that mimics natural tears. It provides sustained hydration and protection to the cornea and conjunctiva, reducing friction and irritation associated with dry eye disease. The unit dose (UD) format ensures sterility and convenience for single-use application.
Approved indications
- Dry eye disease / Keratoconjunctivitis sicca
Common side effects
- Temporary blurred vision
- Eye irritation or discomfort
- Ocular hyperemia
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Systane Ultra UD CI brief — competitive landscape report
- Systane Ultra UD updates RSS · CI watch RSS
- Ocuwize LTD portfolio CI